SRPT in the 13F filings
Sarepta Therapeutics Inc · CUSIP 803607100
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 28
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 6 listed it in both
- Shares listed
- 19,664,780
- combined, among listed positions
- Reported value
- $423m
- combined, at the quarter end
Among the 92 comparable managers: 16 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,776,526.
Managers listing SRPT in Q4 2025
28 of 28 holders
Largest increases and reductions, by shares
Increases
- AQR Capital Management LLCexisting position · 7,796,535 shares now+6,390,860
- Millennium Management LLCexisting position · 1,000,109 shares now+715,899
- Two Sigma Investments LPexisting position · 2,441,455 shares now+303,691
- Point72 Asset Management LPnew position · 207,513 shares now+207,513
- Walleye Capital LLCexisting position · 272,732 shares now+115,952
Reductions
- Renaissance Technologies LLCexisting position · 1,159,578 shares now-1,490,600
- Susquehanna International Group LLPexisting position · 427,609 shares now-563,257
- D. E. Shaw & Co.existing position · 1,540,390 shares now-466,635
- Invesco Ltdexisting position · 397,001 shares now-435,637
- Voloridge Investment Management LLCexisting position · 878,393 shares now-430,345
New positions and exits
New (3)
Exited (4)
- Tudor Investment Corpwas $2.9m
- Verition Fund Management LLCwas $2.9m
- ExodusPoint Capital Management LPwas $1.2m
- Freestone Grove Partners LPwas $357k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $52m | n.a. | n.a. |
| Q3 2013 | 3 | $62m | n.a. | n.a. |
| Q4 2013 | 1 | $4.7m | n.a. | n.a. |
| Q1 2014 | 1 | $601k | n.a. | n.a. |
| Q2 2014 | 3 | $68m | n.a. | n.a. |
| Q3 2014 | 2 | $12m | n.a. | n.a. |
| Q4 2014 | 1 | $22m | n.a. | n.a. |
| Q1 2015 | 1 | $23m | n.a. | n.a. |
| Q2 2015 | 2 | $31m | n.a. | n.a. |
| Q3 2015 | 5 | $74m | n.a. | n.a. |
| Q4 2015 | 2 | $129m | n.a. | n.a. |
| Q1 2016 | 1 | $58m | n.a. | n.a. |
| Q2 2016 | 3 | $62m | n.a. | n.a. |
| Q3 2016 | 10 | $425m | n.a. | n.a. |
| Q4 2016 | 5 | $48m | n.a. | n.a. |
| Q1 2017 | 6 | $58m | n.a. | n.a. |
| Q2 2017 | 4 | $123m | n.a. | n.a. |
| Q3 2017 | 6 | $239m | n.a. | n.a. |
| Q4 2017 | 8 | $150m | n.a. | n.a. |
| Q1 2018 | 8 | $1.1bn | n.a. | n.a. |
| Q2 2018 | 20 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 10 | $2.6bn | n.a. | n.a. |
| Q4 2018 | 13 | $2.1bn | n.a. | n.a. |
| Q1 2019 | 11 | $2.4bn | n.a. | n.a. |
| Q2 2019 | 11 | $2.9bn | n.a. | n.a. |
| Q3 2019 | 8 | $1.2bn | n.a. | n.a. |
| Q4 2019 | 9 | $2.5bn | n.a. | n.a. |
| Q1 2020 | 11 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.6bn | n.a. | n.a. |
| Q3 2020 | 11 | $3.1bn | n.a. | n.a. |
| Q4 2020 | 13 | $4.0bn | n.a. | n.a. |
| Q1 2021 | 11 | $1.3bn | n.a. | n.a. |
| Q2 2021 | 9 | $1.0bn | n.a. | n.a. |
| Q3 2021 | 10 | $1.2bn | n.a. | n.a. |
| Q4 2021 | 13 | $1.2bn | n.a. | n.a. |
| Q1 2022 | 12 | $1.1bn | n.a. | n.a. |
| Q2 2022 | 13 | $946m | n.a. | n.a. |
| Q3 2022 | 21 | $1.8bn | n.a. | n.a. |
| Q4 2022 | 21 | $1.9bn | n.a. | n.a. |
| Q1 2023 | 20 | $2.3bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.8bn | n.a. | n.a. |
| Q3 2023 | 19 | $2.1bn | n.a. | n.a. |
| Q4 2023 | 12 | $1.3bn | 6 | 10 |
| Q1 2024 | 15 | $2.0bn | 9 | 5 |
| Q2 2024 | 15 | $2.0bn | 8 | 9 |
| Q3 2024 | 12 | $1.4bn | 7 | 5 |
| Q4 2024 | 9 | $1.2bn | 4 | 5 |
| Q1 2025 | 11 | $665m | 9 | 3 |
| Q2 2025 | 5 | $175m | 5 | 1 |
| Q3 2025 | 6 | $164m | 2 | 3 |
| Q4 2025 | 7 | $298m | 16 | 15 |
| Q1 2026 | 5 | $281m | 18 | 11 |
| Q2 2026 | 5 | $132m | 14 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
SRPT and LLY →SRPT and JNJ →SRPT and VRTX →Choose a stock to compare with SRPT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own SRPT, latest filings →Back to the 13F Explorer →